Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation

Protocol No
CTN-1702
Principal Investigator
James Jerkins
Phase
N/A
Summary
To determine whether it is better to recieve a transplant from a matched unrelated donor or an alternative donor such as haploidentical, cord blood or mismatched unrelated donor
Description
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic BMT
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Share This: